시장보고서
상품코드
1944410

출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 기기 유형별, 치료 유형별, 최종사용자별, 기술별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Hemorrhagic & Ischemic Stroke Treatment Devices Market, By Device Type, By Treatment Type, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 321 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

출혈성 및 허혈성 뇌졸중 치료 기기 시장 규모는 2024년에 36억 1,098만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 6.10%로 확대될 전망입니다.

출혈성 및 허혈성 뇌졸중 치료 기기는 뇌출혈(출혈) 또는 허혈(폐색)로 인한 급성 뇌졸중의 진단, 중재 및 관리를 위해 설계된 전문 의료기기입니다. 이들 기기에는 신경혈관 스텐트, 혈전제거 시스템, 색전 코일, 혈류 전환 기기, 마이크로카테터, 두개내압 모니터 등이 포함되며, 혈류 회복과 출혈을 조절할 수 있는 최소침습적 혈관 내 시술을 가능하게 합니다. 현대의 뇌졸중 치료 기기는 정밀한 탐색, 첨단 영상 통합, 생체적합성 재료, 안전성 향상에 중점을 두고 있습니다. 혁신은 AI 지원 영상 유도 중재, 차세대 혈전제거 도구, 강화된 지혈 기술에 초점을 맞추고 있습니다. 시장 기회는 고령화 및 생활습관 요인으로 인한 뇌졸중 발생률 증가, 뇌졸중 치료 인프라 확충, 유리한 보험급여 정책, 선진국 및 신흥국 의료 시스템 모두에서 최소침습적 시술의 보급 확대에서 비롯됩니다.

출혈성 및 허혈성 뇌졸중 치료 기기 시장 - 시장 역학

기업의 디지털화 진전, 문서 보안 요구, 비용 효율성이 시장 수요 견인

기업 및 정부 기관의 디지털 전환이 진행됨에 따라 빠르고 안전하며 비용 효율적인 인쇄 솔루션에 대한 수요가 가속화되고 있습니다. IDC에 따르면, 2023년 전 세계 사무용 인쇄량은 2조 3,000억 페이지가 넘을 것으로 예상되며, 레이저 프린터는 낮은 페이지 단가와 고부하 환경에서의 내구성으로 인해 레이저 프린터가 주류를 차지할 것으로 예상됩니다. 보안에 대한 우려도 도입을 촉진하는 요인입니다. IBM의 '데이터 침해 비용 보고서 2024'에 따르면, 데이터 침해의 82%는 문서 오처리를 포함한 인적 오류로 인해 발생하며, 이로 인해 조직은 보안 인쇄 릴리스, 암호화, 액세스 제어가 가능한 레이저 인쇄 시스템을 도입해야 합니다. 또한, 관리형 프린트 서비스(MPS)에 대한 기업 IT 지출은 2024년 전 세계적으로 550억 달러를 돌파할 것으로 예상되며, 이는 중앙 집중식 효율적인 인쇄 관리로의 강력한 전환 추세를 반영하고 있습니다. 하이브리드 작업 모델의 보급과 다기능 레이저 프린터의 채택 확대도 시장 성장을 촉진하고 있습니다. 이는 조직이 신뢰할 수 있고, 네트워크 연결이 가능하며, 에너지 절약형 인쇄 인프라를 찾는 추세가 강화되고 있기 때문입니다.

출혈성 및 허혈성 뇌졸중 치료 기기 시장 - 시장 세분화 분석:

세계 출혈성 및 허혈성 뇌졸중 치료 기기 시장은 기기 유형, 치료법, 최종사용자, 기술, 지역별로 세분화되어 있습니다.

기기 유형별로는 기계적 혈전제거 기기, 동맥류 코일링 및 클리핑 기기, 혈전용해제 전달 시스템, 스텐트 리트리버, 지혈 기기로 분류됩니다. 세계보건기구(WHO)에 따르면 전 세계 뇌졸중 사례의 약 65%를 차지하는 허혈성 뇌졸중 치료에 있어 기계식 혈전제거 기기는 중요한 역할을 담당하고 있어 시장을 독점하고 있습니다. 최소침습적 동맥류 코일링 및 클리핑 기기는 전 세계 뇌졸중 사례의 약 30%를 차지하는 출혈성 뇌졸중 관리에 필수적입니다. 혈전용해제 전달 시스템은 초기 허혈성 뇌졸중 치료의 표준 치료법으로 자리매김하고 있습니다. 스텐트 리트리버와 지혈 기기는 뇌졸중 중재시 시술의 성과와 안전성을 더욱 향상시킵니다.

치료 유형에 따라 시장은 허혈성 뇌졸중 치료와 출혈성 뇌졸중 치료로 세분화됩니다. 허혈성 뇌졸중 치료 부문이 가장 큰 비중을 차지하고 있으며, 이는 2021년 질병부담연구(GBD) 추정에 따르면 연간 약 780만 건의 허혈성 뇌졸중 발생률과 일치하는 것으로 나타났습니다. 뇌내출혈 및 지주막하 출혈을 포함한 출혈성 뇌졸중 치료는 연간 약 400만 건의 신규 환자 발생을 차지하며, 동맥류 관리 및 출혈 제어를 위한 첨단 기기의 채택이 증가함에 따라 꾸준한 성장세를 보이고 있습니다.

출혈성 및 허혈성 뇌졸중 치료 기기 시장 - 지역별 분석

세계 출혈성 및 허혈성 뇌졸중 치료 기기 시장은 의료 인프라의 발전, 정부의 보건 정책, 뇌졸중 유병률, 상환 정책 등의 영향으로 지역별로 큰 차이를 보이고 있습니다.

북미는 선진화된 의료 인프라, 최소침습적 뇌졸중 치료법의 광범위한 보급, 뇌졸중 치료에 대한 정부의 강력한 재정적 지원에 힘입어 가장 큰 시장 점유율을 차지하고 있습니다. 미국 질병예방통제센터(CDC)에 따르면, 미국에서는 연간 약 79만 5,000건의 새로운 뇌졸중 사례가 보고되고 있어 첨단 뇌졸중 치료 기기의 필요성이 강조되고 있습니다. 또한, 메디케어와 민간 보험사들이 신경혈관 중재술에 대한 종합적인 보험 적용을 제공하면서 시장 성장을 촉진하고 있습니다.

유럽은 높은 인지도, 잘 구축된 뇌졸중 센터, 조기 진단 및 치료를 촉진하는 정부 프로그램에 힘입어 북미에 이어 두 번째로 큰 시장입니다. 유럽뇌졸중기구(ESO)에 따르면, 유럽에서는 연간 약 110만 건의 새로운 뇌졸중 사례가 발생하고 있으며, 회원국 간 뇌졸중 치료의 표준화를 위한 노력이 계속되고 있습니다.

미국의 출혈성 및 허혈성 뇌졸중 치료 기기 시장 - 국가별 분석

미국은 막대한 의료비 지출과 선진화된 뇌졸중 치료 인프라를 바탕으로 전 세계 출혈성 및 허혈성 뇌졸중 치료 기기 시장을 주도하고 있습니다. 미국심장협회(AHA)에 따르면, 2023년 뇌졸중 관련 치료 및 재활에 대한 미국 의료비 지출은 460억 달러를 넘어섰습니다.

메디케어-메디케이드 서비스 센터(CMS)의 보고에 따르면, 상환 정책은 기계적인 혈전제거술과 혈관 내 치료를 점점 더 우선시하는 경향이 있으며, 2022년 기준 전국적으로 연간 약 4만 5,000건의 혈전제거술이 시행될 것으로 예상됩니다. 또한, 미국에는 250개 이상의 공동위원회 인증 종합 뇌졸중 센터가 존재하여 최첨단 뇌졸중 치료 기기의 신속한 도입이 가능합니다.

목차

제1장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 개요

제2장 주요 요약

제3장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 주요 시장 동향

제4장 출혈성 및 허혈성 뇌졸중 치료 기기 산업 조사

제5장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 높아지는 지정학적 긴장의 영향

제6장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 구도

제7장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 기기 유형별

제8장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 치료 유형별

제9장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 최종사용자별

제10장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 기술별

제11장 출혈성 및 허혈성 뇌졸중 치료 기기 시장 : 지역별

제12장 주요 벤더 분석 : 출혈성 및 허혈성 뇌졸중 치료 기기 업계

제13장 애널리스트에 의한 전방위 전망

KSM

Hemorrhagic & ischemic stroke treatment devices market size was valued at US$ 3,610.98 Million in 2024, expanding at a CAGR of 6.10% from 2025 to 2032.

Hemorrhagic and ischemic stroke treatment devices are specialized medical instruments designed for the diagnosis, intervention, and management of acute stroke caused by cerebral hemorrhage (bleeding) or ischemia (blockage). These devices include neurovascular stents, thrombectomy systems, embolization coils, flow diverters, microcatheters, and intracranial pressure monitors, enabling minimally invasive endovascular procedures that restore blood flow or control bleeding. Modern stroke treatment devices emphasize precision navigation, advanced imaging integration, biocompatible materials, and improved safety profiles. Innovations focus on AI-assisted image-guided interventions, next-generation thrombectomy tools, and enhanced hemostatic technologies. Market opportunities arise from growing stroke incidence due to aging populations and lifestyle factors, expanding stroke care infrastructure, favorable reimbursement policies, and increased adoption of minimally invasive procedures in both developed and emerging healthcare systems.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Market Dynamics

Growing enterprise digitization, document security needs, and cost-efficiency to propel market demand

Rising digital transformation across enterprises and government institutions is accelerating demand for high-speed, secure, and cost-efficient printing solutions. According to IDC, global office printing volumes exceeded 2.3 trillion pages in 2023, with laser printers accounting for the majority due to lower cost per page and higher durability in high-volume environments. Security concerns are also driving adoption. IBM's Cost of a Data Breach Report 2024 states that 82% of data breaches involve human error, including document mishandling, pushing organizations to adopt secure print release, encryption, and access-controlled laser printing systems. Additionally, enterprise IT spending on managed print services (MPS) crossed USD 55 billion globally in 2024, reflecting a strong shift toward centralized, efficient print management. The growing adoption of hybrid work models and multifunction laser printers further supports market growth, as organizations seek reliable, network-connected, and energy-efficient printing infrastructure.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Segmentation Analysis:

The Global Hemorrhagic & Ischemic Stroke Treatment Devices Market is segmented on the basis of Device Type, Treatment Type, End User, Technology, and Region.

Based on Device Type, the market is categorized into Mechanical Thrombectomy Devices, Aneurysm Coiling and Clipping Devices, Thrombolytic Drug Delivery Systems, Stent Retrievers, and Hemostasis Devices. Mechanical thrombectomy devices dominate the market due to their critical role in treating ischemic strokes, which constitute approximately 65% of all stroke cases globally, according to the World Health Organization (WHO). Minimally invasive aneurysm coiling and clipping devices are essential for managing hemorrhagic strokes, which make up nearly 30% of stroke cases worldwide. Thrombolytic drug delivery systems remain a standard of care for early ischemic stroke treatment. Stent retrievers and hemostasis devices further enhance procedural outcomes and safety during stroke interventions.

Based on Treatment Type, the market is divided into Ischemic Stroke Treatment and Hemorrhagic Stroke Treatment segments. The ischemic stroke treatment segment holds the largest share, consistent with the global incidence of ischemic strokes accounting for about 7.8 million new cases annually, as estimated by the Global Burden of Disease (GBD) study 2021. Hemorrhagic stroke treatment, covering intracerebral and subarachnoid hemorrhages, which together account for around 4 million new cases per year, is witnessing steady growth with rising adoption of advanced devices for aneurysm management and bleeding control.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Geographical Insights

The global hemorrhagic and ischemic stroke treatment devices market shows significant regional variation influenced by healthcare infrastructure development, government health initiatives, stroke prevalence, and reimbursement policies.

North America holds the largest market share, supported by advanced healthcare infrastructure, widespread adoption of minimally invasive stroke interventions, and strong government funding for stroke care. According to the Centers for Disease Control and Prevention (CDC), the United States reports approximately 795,000 new stroke cases annually, emphasizing the need for sophisticated stroke treatment devices. Additionally, Medicare and private insurers provide comprehensive coverage for neurovascular interventions, bolstering market growth.

Europe follows closely, driven by high awareness levels, well-established stroke centers, and government programs promoting early stroke diagnosis and treatment. The European Stroke Organisation (ESO) notes that Europe experiences about 1.1 million new stroke cases each year, with ongoing efforts to standardize stroke care across member countries.

U.S. Hemorrhagic & Ischemic Stroke Treatment Devices Market- Country Insights

The United States dominates the global hemorrhagic and ischemic stroke treatment devices market, supported by substantial healthcare expenditure and advanced stroke care infrastructure. In 2023, the U.S. healthcare spending on stroke-related treatments and rehabilitation exceeded USD 46 billion, according to the American Heart Association (AHA).

The Centers for Medicare & Medicaid Services (CMS) reports that reimbursement policies increasingly favor mechanical thrombectomy and endovascular procedures, with nearly 45,000 thrombectomy procedures performed annually across the country as of 2022. Additionally, the U.S. has over 250 Comprehensive Stroke Centers certified by The Joint Commission, enabling rapid adoption of state-of-the-art stroke intervention devices.

Hemorrhagic & Ischemic Stroke Treatment Devices Market- Competitive Landscape:

Rising stroke prevalence, technological advancements, and increasing demand for minimally invasive treatment options are intensifying competition across the global stroke treatment device ecosystem. Major players include Medtronic, Balt, Terumo Corporation, Scientia Vascular, Inc., Johnson & Johnson (MedTech), MicroPort Scientific Corporation, phenox GmbH (Wallaby Medical), B. Braun SE, and others. These companies compete through device innovation, clinical efficacy, regulatory approvals, and extensive sales and distribution networks. Common strategies include expanding portfolios of thrombectomy systems, aneurysm coiling and clipping devices, investing in AI-powered image-guided intervention technologies, and enhancing catheter and stent designs for improved patient outcomes. Many firms are also focusing on strategic partnerships with healthcare providers and research institutions to accelerate clinical trials and adoption, while emphasizing compliance with evolving global regulatory standards and reimbursement frameworks.

Recent Developments:

In January 2026, Penumbra introduced the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT(TM)) system, featuring enhanced clot detection, enlarged tubing, and automated backflush for faster, safer clot removal. The upgrade aims to improve procedural efficiency and fluid management, building on prior CAVT advancements in mechanical thrombectomy technology.

In February 2025, Johnson & Johnson MedTech launched the CEREGLIDE(TM) 92 Catheter System in the U.S., a next generation .092" large bore neurovascular catheter with INNERGLIDE(TM) 9 delivery aid. Designed for improved distal access and flow reduction during acute ischemic stroke interventions, it supports enhanced device navigation and integration with stroke device portfolios.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Balt
  • Terumo Corporation
  • Scientia Vascular, Inc.
  • Johnson & Johnson (MedTech)
  • MicroPort Scientific Corporation
  • phenox GmbH (Wallaby Medical)
  • B. Braun SE
  • Acandis GmbH
  • Infinity Neuro LLC
  • Integra LifeSciences
  • Penumbra, Inc.
  • Stryker
  • Boston Scientific Corporation
  • Vesalio Inc.
  • Peter LAZIC GmbH
  • Others

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mechanical Thrombectomy Devices
  • Aneurysm Coiling and Clipping Devices
  • Thrombolytic Drug Delivery Systems
  • Stent Retrievers
  • Hemostasis Devices

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ischemic Stroke Treatment
  • Hemorrhagic Stroke Treatment

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Catheter-Based Systems
  • Surgical Instruments
  • Imaging and Navigation Systems

GLOBAL HEMORRHAGIC & ISCHEMIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Device Type
    • 2.1.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Treatment Type
    • 2.1.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by End User
    • 2.1.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Technology
    • 2.1.5. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Country
    • 2.1.6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemorrhagic & Ischemic Stroke Treatment Devices Key Market Trends

  • 3.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Opportunities
  • 3.4. Hemorrhagic & Ischemic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic & Ischemic Stroke Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Landscape

  • 6.1. Hemorrhagic & Ischemic Stroke Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
    • 7.1.2. Mechanical Thrombectomy Devices
    • 7.1.3. Aneurysm Coiling and Clipping Devices
    • 7.1.4. Thrombolytic Drug Delivery Systems
    • 7.1.5. Stent Retrievers
    • 7.1.6. Hemostasis Devices

8. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 8.1.2. Ischemic Stroke Treatment
    • 8.1.3. Hemorrhagic Stroke Treatment

9. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics

10. Hemorrhagic & Ischemic Stroke Treatment Devices Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 10.1.2. Catheter-Based Systems
    • 10.1.3. Surgical Instruments
    • 10.1.4. Imaging and Navigation Systems

11. Hemorrhagic & Ischemic Stroke Treatment Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Hemorrhagic & Ischemic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic & Ischemic Stroke Treatment Devices Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Medtronic
    • 12.2.2. Balt
    • 12.2.3. Terumo Corporation
    • 12.2.4. Scientia Vascular, Inc.
    • 12.2.5. Johnson & Johnson (MedTech)
    • 12.2.6. MicroPort Scientific Corporation
    • 12.2.7. phenox GmbH (Wallaby Medical)
    • 12.2.8. B. Braun SE
    • 12.2.9. Acandis GmbH
    • 12.2.10. Infinity Neuro LLC
    • 12.2.11. Integra LifeSciences
    • 12.2.12. Penumbra, Inc.
    • 12.2.13. Stryker
    • 12.2.14. Boston Scientific Corporation
    • 12.2.15. Vesalio Inc.
    • 12.2.16. Peter LAZIC GmbH
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제